D-0044-2024 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0044-2024 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Oct 4, 2023 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Feb 2, 2024). Affected quantity: 144 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 25, 2023
Initiation Date
Oct 4, 2023
Termination Date
Feb 2, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
144 bottles

Product description

Bupropion Hydrochloride Extended-Release Tablets USP (SR), 150 mg, 60 tablets bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 47335-737-86

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide in the USA.

Code information

Lot #: HAD0360A, Exp. 12/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0044-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0044-2024. Report a data issue: hello@regdatalab.com.